title: [Adverse effect of sclerosants on the liver, kidney and lung].
authors.affiliation: 1st Department of Surgery, St. Marianna University School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Sakai
authors.forename: M
authors.initials: M
authors.lastname: Hagiwara
authors.forename: T
authors.initials: T
authors.lastname: Okano
authors.forename: S
authors.initials: S
authors.lastname: Nakano
authors.forename: S
authors.initials: S
authors.lastname: Nagaoka
authors.forename: J
authors.initials: J
authors.lastname: Ikari
authors.forename: S
authors.initials: S
authors.lastname: Kubota
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
mesh_terms: D004932:Esophageal and Gastric Varices / Q000628:therapy; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology* / Q000517:prevention & control; D008107:Liver Diseases / Q000209:etiology* / Q000517:prevention & control; D008875:Middle Aged; D010996:Pleural Effusion / Q000209:etiology* / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000209:etiology* / Q000517:prevention & control; D012306:Risk; D012597:Sclerosing Solutions / Q000009:adverse effects*
chemical_list: D012597:Sclerosing Solutions